CD Biosynsis has established a comprehensive synthetic biology platform to help our customers develop effective synthetic biology strategies to optimize the biological production pathway of collagens. We are committed to removing all obstacles encountered in producing collagen and promoting the widespread application of collagen in the biomedical, pharmaceutical, food, and cosmetic fields.
Collagen is the most abundant protein in the human body and has a wide range of applications in the food, cosmetic, pharmaceutical, and biomedical industries. Currently, the main way to obtain collagen is by extracting it from animal tissues. However, collagen obtained in this manner has many limitations in its application and there are problems associated with animal-derived materials such as immunogenicity and cross-species transmission of disease. These concerns and issues have stimulated enthusiasm for the development of cellular and microbial factories for collagen production. The revolutionary technology of synthetic biology has unprecedented capabilities in the design and construction of microbial and cellular factories for collagen production, which will greatly advance the use of collagen in a wide range of applications.
Figure 1. Schematic representation of recombinant bacterial collagen construct. (Brodsky B, et al., 2017)
CD Biosynsis has established a multidisciplinary team with expertise and experience in synthetic biology, genetic engineering, and protein engineering to help our customers develop effective solutions to overcome all difficulties in the production and application of collagens. Our dedicated and highly creative scientists can develop customized collagen production processes based on our customers' specific downstream application needs in order to drive large-scale applications of collagen in a wide range of fields.
We are able to regulate the key nodes of heterologous expression of human-like collagen resolved by metabolic engineering techniques to achieve efficient synthesis of human-like collagen in microorganisms.
We can help our customers produce human-like collagen using DNA recombinant technology.
We can use tissue engineering principles to optimize the types of cell growth factors and environmental conditions for cell culture expansion during collagen synthesis.
We used genetic circuit design technology to regulate gene expression and reduce the cellular load caused by heterogeneous protein overexpression.
Microbial Chassis Development for Collagen Production
Leveraging our advanced technologies in bacterial synthetic biology and fungal synthetic biology, we can help our customers directionally design and modify microbial chassis to create engineered microorganisms with excellent collagen production performance. Our experienced scientists can optimize the biosynthetic pathway of collagen to increase yield and productivity. The following are the microbial strains that we have developed for collagen production. If you are interested in other strains, please fill out the online inquiry form and tell us more about your project.
Legionella pneumophila | Bacillus anthracis | Escherichia coli | Saccharomyces cerevisiae | Pichia pastoris |
Clostridium Perfringens | Streptococcus Pyogenes Scl2 | Rhodopseudomonas palustris | Methylobacterium sp. | Streptococcus Pyogenes Scl1 |
Construction of a Cell Factory for Collagen Production
Many primary and immortalized cells have been used to produce various types of collagens from a variety of species. however, cell-based approaches to collagen production have yielded very limited proteins. Leveraging our advanced technology in the field of cellular synthetic biology, our specialized scientists can harness innovative thinking based on engineering principles to program living cells using artificial genetic circuits to develop cells with powerful biosynthetic activity and rapid growth. We are committed to helping our customers establish efficient cell factories for collagen production, including but not limited to plant cell factories, mammalian cell factories, and insect cell factories. If you are interested in our Cell & Tissue Engineering services, please fill out our online inquiry form and tell us more about your project.
Incorporation of Non-Natural Amino Acids
Non-natural amino acids can exhibit structures and functions not found in 20 natural amino acids, offering the possibility of enhanced protein function or the generation of new protein properties. We achieve in vivo specific incorporation of non-natural amino acids by gene encoding insertion of non-natural amino acids.
CD Biosynsis offers our expertise and experience in protein synthetic biology to help our customers realize the great potential of collagens in a variety of applications.
CD Biosynsis provides the most comprehensive and efficient solutions for synthetic biology workflows. We are committed to helping our customers solve all problems encountered in protein and peptide production to advance their applications in a wide range of fields. Each of our deliverables will undergo a rigorous quality inspection test to ensure the reliability and accuracy of the results. If you are interested in our services or have any further questions, please do not hesitate to contact us.
References
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.